Analysts have maintained ‘buy’ ratings on pharmaceuticals, steel, and financial stocks, expecting profitable growth. Akums Drugs aims to boost margins, JSW Steel foresees strong demand and price benefits, and Bajaj Finserv’s fundamentals remain intact post-split with Allianz. Va Tech Wabag and Baazar Style Retail see robust growth potential.
Buy or sell: Stocks on brokerages’ radar for today
